Synonyms Refractory Transformed B-Cell Non-Hodgkin Lymphoma, Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma |
Introduction An indolent B-cell non-Hodgkin lymphoma which has undergone histologic transformation to an aggressive B-cell non-Hodgkin lymphoma and has become resistant to treatment. |
Target |
Mechanism IL-15Rα stimulants |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2/3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CD20 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date22 Apr 2024 |
Sponsor / Collaborator Le LYSARC [+1] |
Start Date15 Apr 2024 |
Sponsor / Collaborator |
Start Date30 Jan 2024 |
Sponsor / Collaborator |